After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Bharat Biotech, the manufacturer of Covaxin, has submitted data for clinical trials in the age group of 2-18 years to Central Drugs Standard Control Organisation (CDSCO).
The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations. (ANI)
Download Organiser Mobile App:
Mobile App: https://play.google.com/store/apps/de...
Visit Us At:
Follow us on:
Background Music Credits: https://www.bensound.com
The violent Islamists started attacking and vandalising multiple pooja pandals when the Hindus were celebrating the Navratri festival. The United States condemned the attack on Hindus in Bangladesh, saying freedom of religion or belief is a human right. The US expressed its concern over the recent violent attacks on Hindu temples and businesses and urged Bangladesh to probe the recent attacks. “We condemn the recent violent attacks on Hindu temples and businesses in Bangladesh d ...